These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 6798910)
1. [Ticarcillin activity in immunodepressed mice infected with "Pseudomonas aeruginosa" (author's transl)]. Fauchère JL; Simonet M; de Meirleire F; Véron M Ann Microbiol (Paris); 1981; 132B(2):215-24. PubMed ID: 6798910 [TBL] [Abstract][Full Text] [Related]
2. [In vitro susceptibility of Pseudomonas aeruginosa against ticarcillin (author's transl)]. Zaror L; Otth L; Gutiérrez A Rev Med Chil; 1978 Feb; 106(2):118-9. PubMed ID: 418471 [No Abstract] [Full Text] [Related]
3. Enhanced killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes in presence of subinhibitory concentrations of carbenicillin and ticarcillin. Petit JC; Daguet GL Biomedicine; 1981 Feb; 34(1):29-33. PubMed ID: 6784781 [TBL] [Abstract][Full Text] [Related]
4. [Klebsiella pneumoniae infection in immunosuppressed mice treated with gentamicin (author's transl)]. Fauchère JL; Berche P; Véron M; Kreis H; Crosnier J Ann Microbiol (Paris); 1978; 129(4):433-46. PubMed ID: 358887 [TBL] [Abstract][Full Text] [Related]
5. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)]. Petit JC; Richard G; Burghoffer B; Daguet GL Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286 [TBL] [Abstract][Full Text] [Related]
6. Inability of carbenicillin to predict ticarcillin activity versus Pseudomonas aeruginosa by disc-agar diffusion. Flournoy DJ Methods Find Exp Clin Pharmacol; 1982; 4(2):119-20. PubMed ID: 6811811 [No Abstract] [Full Text] [Related]
7. [Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis]. de Meirleire F; Fauchere JL; Simon G Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):570-2. PubMed ID: 6431381 [TBL] [Abstract][Full Text] [Related]
8. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)]. Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287 [TBL] [Abstract][Full Text] [Related]
9. [An acellular vaccine from "Pseudomonas aeruginosa." I. Preparation and activity (author's transl)]. Berche P; Véron M; Tinelli R Ann Microbiol (Paris); 1976; 127A(2):247-59. PubMed ID: 822769 [TBL] [Abstract][Full Text] [Related]
10. In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa. Gerber AU; Feller-Segessenmann C J Antimicrob Chemother; 1985 Jan; 15 Suppl A():201-6. PubMed ID: 3920180 [TBL] [Abstract][Full Text] [Related]
11. Reduced susceptibility of a mucoid strain of Pseudomonas aeruginosa to lysis by ticarcillin and piperacillin. Bolister N; Basker M; Hodges N; Marriott C J Antimicrob Chemother; 1989 Oct; 24(4):619-21. PubMed ID: 2515190 [No Abstract] [Full Text] [Related]
12. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa. Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360 [No Abstract] [Full Text] [Related]
13. [Development of Pseudomonas aeruginosa infection in mice with trichinellosis]. Bany J; Pfeffer M; Golińska Z; Zdanowska D Wiad Parazytol; 2001; 47(4):667-74. PubMed ID: 16886408 [TBL] [Abstract][Full Text] [Related]
14. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antipseudomonal activity, acute toxicity, and mode of action of a newly synthesized fluoroquinolonyl ampicillin derivative. Lin WP; Ji DD; Shiau CY; Yang TC; Yang YW; Tsou TL; Tang ST; Chen CH; Liu YT J Lab Clin Med; 2003 Sep; 142(3):158-65. PubMed ID: 14532903 [TBL] [Abstract][Full Text] [Related]
17. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study]. Cavallo JD; Leblanc F; Fabre R Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844 [TBL] [Abstract][Full Text] [Related]
18. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related]
19. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice. Sokalska M; Maresz-Babczyszyn J Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542 [TBL] [Abstract][Full Text] [Related]
20. Experimental studies on mice challenged intracerebrally with Pseudomonas aeruginosa. Campanile F; Puccetti P; Angeli G; Fioretti MC; Bonmassar E Int J Tissue React; 1984; 6(5):421-6. PubMed ID: 6519921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]